These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34331108)

  • 61. Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
    Wang SS; Hsiao R; Limpar MM; Lomahan S; Tran TA; Maloney NJ; Ikegaki N; Tang XX
    Int J Mol Med; 2014 Jan; 33(1):35-42. PubMed ID: 24190252
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
    Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
    Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The epigenetic control of E-box and Myc-dependent chromatin modifications regulate the licensing of lamin B2 origin during cell cycle.
    Swarnalatha M; Singh AK; Kumar V
    Nucleic Acids Res; 2012 Oct; 40(18):9021-35. PubMed ID: 22772991
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells.
    Kapp N; Stander XX; Stander BA
    Anticancer Drugs; 2018 Jun; 29(5):429-439. PubMed ID: 29561307
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
    Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
    Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
    Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
    Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells.
    Shinji S; Nakamura S; Nihashi Y; Umezawa K; Takaya T
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):63-75. PubMed ID: 31462179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation.
    Mazzoccoli L; Robaina MC; Bacchi CE; Soares Lima SC; Klumb CE
    Oncol Rep; 2019 Aug; 42(2):775-784. PubMed ID: 31173259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma.
    Chen EY; Dobrinski KP; Brown KH; Clagg R; Edelman E; Ignatius MS; Chen JY; Brockmann J; Nielsen GP; Ramaswamy S; Keller C; Lee C; Langenau DM
    PLoS Genet; 2013 Aug; 9(8):e1003727. PubMed ID: 24009521
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Ragab N; Bauer J; Botermann DS; Uhmann A; Hahn H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948179
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting oxidative stress in embryonal rhabdomyosarcoma.
    Chen X; Stewart E; Shelat AA; Qu C; Bahrami A; Hatley M; Wu G; Bradley C; McEvoy J; Pappo A; Spunt S; Valentine MB; Valentine V; Krafcik F; Lang WH; Wierdl M; Tsurkan L; Tolleman V; Federico SM; Morton C; Lu C; Ding L; Easton J; Rusch M; Nagahawatte P; Wang J; Parker M; Wei L; Hedlund E; Finkelstein D; Edmonson M; Shurtleff S; Boggs K; Mulder H; Yergeau D; Skapek S; Hawkins DS; Ramirez N; Potter PM; Sandoval JA; Davidoff AM; Mardis ER; Wilson RK; Zhang J; Downing JR; Dyer MA;
    Cancer Cell; 2013 Dec; 24(6):710-24. PubMed ID: 24332040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
    Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
    Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation.
    Tomasiak P; Janisiak J; Rogińska D; Perużyńska M; Machaliński B; Tarnowski M
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.
    Kalac M; Scotto L; Marchi E; Amengual J; Seshan VE; Bhagat G; Ulahannan N; Leshchenko VV; Temkin AM; Parekh S; Tycko B; O'Connor OA
    Blood; 2011 Nov; 118(20):5506-16. PubMed ID: 21772049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
    Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
    Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
    Shaker S; Bernstein M; Momparler LF; Momparler RL
    Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Defining an embryonal rhabdomyosarcoma endotype.
    Ricker CA; Crawford K; Matlock K; Lathara M; Seguin B; Rudzinski ER; Berlow NE; Keller C
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.
    Eberhardy SR; D'Cunha CA; Farnham PJ
    J Biol Chem; 2000 Oct; 275(43):33798-805. PubMed ID: 10931841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.